National Research Q3 EPS $0.32 vs $0.33 YoY; HUP adopted by 91 orgs

NRC HEALTH

2023-Q3 EPS reported $0.89 revenue$110,579,000

Diluted EPS $0.32 for Q3 2023, down from $0.33 in Q3 2022.
New sales grew YoY; Human Understanding Program adopted by 91 healthcare organizations.
Sequential quarterly operating margin improvement in last two quarters; focus on returning to historical margins.
Net debt ~$20M; $25M revolver available; paid $27.5M dividends, $310K buybacks in Q3.
Spent $3.7M on innovation and growth investments during quarter.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.8

NRC HEALTH reported third quarter ended September 30, 2023 results: EPS $0.32.

Period: third quarter ended September 30, 2023
EPS: $0.32
Result: reported results

Exact text from the filing

Diluted earnings per share decreased to $0.32 for the quarter ended September 30, 2023, from diluted earnings per share of $0.33 for the quarter ended September 30, 2022.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

NRC HEALTH filing history →

Source: SEC EDGAR

accession 0001437749-23-030911

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.